A. Donetti

664 total citations
51 papers, 499 citations indexed

About

A. Donetti is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, A. Donetti has authored 51 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Organic Chemistry, 24 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in A. Donetti's work include Receptor Mechanisms and Signaling (11 papers), Synthesis and biological activity (9 papers) and Synthesis and Reactions of Organic Compounds (8 papers). A. Donetti is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Synthesis and biological activity (9 papers) and Synthesis and Reactions of Organic Compounds (8 papers). A. Donetti collaborates with scholars based in Italy, Switzerland and Netherlands. A. Donetti's co-authors include Franco Borsini, Marco Turconi, R. Micheletti, E. Giraldo, A. Brambilla, Angelo Ceci, P Schiantarelli, H. Ladinsky, C.A. Rizzi and Massimo Di Nicola and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and British Journal of Pharmacology.

In The Last Decade

A. Donetti

44 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Donetti Italy	12	225	214	175	50	32	51	499
John L. Sawyer United States	16	230 1.0×	186 0.9×	149 0.9×	57 1.1×	62 1.9×	36	650
Ralph A. Lessor United States	14	293 1.3×	93 0.4×	222 1.3×	50 1.0×	45 1.4×	37	534
Steven Dabbs United States	13	401 1.8×	244 1.1×	269 1.5×	57 1.1×	42 1.3×	20	664
Robert M. Riggs United States	15	316 1.4×	284 1.3×	222 1.3×	50 1.0×	35 1.1×	23	752
Kenneth L. Hauser United States	7	239 1.1×	149 0.7×	212 1.2×	97 1.9×	54 1.7×	9	594
M. Hooper United Kingdom	12	136 0.6×	133 0.6×	143 0.8×	37 0.7×	30 0.9×	34	428
Abdelmalik Slassi Canada	15	288 1.3×	295 1.4×	255 1.5×	51 1.0×	26 0.8×	29	602
Abd M. Ismaiel United States	14	469 2.1×	223 1.0×	337 1.9×	54 1.1×	49 1.5×	18	740
W. M. WELCH United States	7	215 1.0×	170 0.8×	219 1.3×	98 2.0×	21 0.7×	12	517
Marco Turconi Italy	13	212 0.9×	151 0.7×	165 0.9×	44 0.9×	40 1.3×	22	404

Countries citing papers authored by A. Donetti

Since Specialization

Citations

This map shows the geographic impact of A. Donetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Donetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Donetti more than expected).

Fields of papers citing papers by A. Donetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Donetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Donetti. The network helps show where A. Donetti may publish in the future.

Co-authorship network of co-authors of A. Donetti

This figure shows the co-authorship network connecting the top 25 collaborators of A. Donetti. A scholar is included among the top collaborators of A. Donetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Donetti. A. Donetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borsini, Franco, et al.. (1995). BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(3). 283–90. 45 indexed citations

Borsini, Franco, E. Giraldo, Eugenia Monferini, et al.. (1995). BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(3). 52–54. 41 indexed citations

Borsini, Franco, et al.. (1993). The Effect of DAU 6215, A Novel 5HT-3 Antagonist, in Animal Models of Anxiety. Pharmacological Research. 27(2). 151–164. 26 indexed citations

Sagrada, A., Marco Turconi, P Schiantarelli, et al.. (1991). Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation. Cancer Chemotherapy and Pharmacology. 28(6). 470–474. 9 indexed citations

Turconi, Marco, et al.. (1991). Malonamic acid derivatives as M1 selective muscarinic receptor antagonists.. PubMed. 46(9). 999–1009. 1 indexed citations

Micheletti, R., et al.. (1990). Hexocyclium derivatives with a high selectivity for smooth muscle muscarinic receptors. British Journal of Pharmacology. 100(1). 150–152. 12 indexed citations

Monferini, Eugenia, et al.. (1990). Guanylpirenzepine Distinguishes Between Neuronal m1 and m4 Muscarinic Receptor Subtypes. Journal of Receptor Research. 10(1-2). 81–96. 3 indexed citations

Turconi, Marco, et al.. (1990). Synthesis of a new class of 2,3-dihydro-2-oxo-1H-benzimidazole-1-carboxylic acid derivatives as highly potent 5-HT3 receptor antagonists. Journal of Medicinal Chemistry. 33(8). 2101–2108. 51 indexed citations

Micheletti, R., et al.. (1990). 4‐DAMP analogues reveal heterogeneity of M₁ muscarinic receptors. British Journal of Pharmacology. 100(3). 395–397. 15 indexed citations

10.

Micheletti, R., et al.. (1990). Affinitu profile of the novel muscarinic antagonist guanylpirenzepine. Life Sciences. 47(15). PL55–PL58. 6 indexed citations

11.

Micheletti, R., et al.. (1990). Synthesis and biological evaluation of new antimuscarinic compounds with amidine basic centers. A useful bioisosteric replacement of classical cationic heads. Journal of Medicinal Chemistry. 33(8). 2108–2113. 19 indexed citations

12.

Donetti, A., et al.. (1989). N-(Fluoroethyl)(imidazolylphenyl)formamidines. The issue of the active species of mifentidine. Journal of Medicinal Chemistry. 32(5). 957–961. 9 indexed citations

13.

Giachetti, Antonio, et al.. (1988). Are the imidazoles of cimetidine and mifentidine bioisostere?. European Journal of Medicinal Chemistry. 23(3). 267–273. 3 indexed citations

14.

Turconi, Marco, et al.. (1987). Anti-secretory and anti-ulcer activities of some new 2-(2-pyridylmethyl-sulfinyl)-benzimidazoles. European Journal of Medicinal Chemistry. 22(6). 527–537. 32 indexed citations

15.

Yamaguchi, Hisao, et al.. (1979). Species differences in the metabolism of feprazone, an antiinflammatory drug. Pharmacological Research Communications. 11(8). 719–730. 4 indexed citations

16.

Donetti, A., et al.. (1976). A SIMPLIFIED PROCEDURE FOR THE SYNTHESIS OF THE 6,7-BENZOMORPHAN NUCLEUS. Organic Preparations and Procedures International. 8(3). 143–146.

17.

Donetti, A., et al.. (1973). Quaternization reactions with the aid of ethylene oxide. Tetrahedron Letters. 14(37). 3573–3576.

18.

Donetti, A., et al.. (1972). Terpene compounds as drugs. X. 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370): a new anti-inflammatory drug, with low ulcerogenic effects, derived from a series of terpenyl pyrazolidinediones.. PubMed. 22(1). Suppl 1a:171–4. 7 indexed citations

19.

Donetti, A., et al.. (1972). Mild and effective two-step conversion of disubstituted cyanamides to secondary amines. The Journal of Organic Chemistry. 37(21). 3352–3353. 8 indexed citations

20.

Donetti, A., et al.. (1971). Synthesis and local anesthetic activity of N-diethylaminoacetyl derivatives of naphthylalkylamines. Journal of Medicinal Chemistry. 14(9). 896–897. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact